## KVUE: Kenvue Inc. - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 0.88 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.3% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($15.95)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. OMERS ADMINISTRATION Corp Reduces Position in Kenvue Inc. $KVUE**
- Source: MarketBeat | 20251202T123947 | Neutral | Relevance: 100%
- OMERS ADMINISTRATION Corp reduced its stake in Kenvue Inc. by 18.6% in Q2 2025, selling 128,300 shares and retaining 560,804 shares valued at $11.74 million. Kenvue reported Q3 EPS of $0.28, beating estimates, but revenue fell 3.5% year-over-year to $3.76 billion, missing analyst projections, and its FY2025 EPS guidance is below sell-side consensus. The company also announced a quarterly dividend of $0.2075 per share, yielding 4.8%, despite a high payout ratio of 110.67%.

**2. Brandes Investment Partners LP Has $37.64 Million Position in Kenvue Inc. $KVUE**
- Source: MarketBeat | 20251202T085941 | Neutral | Relevance: 100%
- Brandes Investment Partners LP significantly reduced its stake in Kenvue Inc. by 38.0% in Q2, but still holds a position valued at $37.64 million. Other institutional investors also adjusted their holdings in Kenvue, with some increasing and others acquiring new positions. The article also provides Kenvue's recent stock performance, analyst ratings, and dividend information.

**3. Scotia Capital Inc. Trims Holdings in Kenvue Inc. $KVUE**
- Source: MarketBeat | 20251201T122246 | Neutral | Relevance: 100%
- Scotia Capital Inc. reduced its stake in Kenvue Inc. by 10.1% in Q2, selling 21,381 shares and ending the quarter with 190,734 shares valued at $3.99 million. Kenvue's stock currently has a consensus "Hold" rating from analysts with a target price of $20.23, following several recent price target reductions. The company reported EPS of $0.28, revenue of $3.76 billion, and offers a quarterly dividend yielding approximately 4.8%.

**4. Inceptionr LLC Acquires New Position in Kenvue Inc. $KVUE**
- Source: MarketBeat | 20251201T112456 | Somewhat-Bearish | Relevance: 100%
- Inceptionr LLC has acquired a new position in Kenvue Inc. by purchasing 14,751 shares valued at approximately $309,000, as detailed in its latest 13F filing. This comes as large institutional investors continue to hold significant stakes in the consumer health company. Kenvue's recent earnings report showed an EPS beat but slightly missed revenue estimates, and the company's dividend payout ratio raises sustainability concerns.

**5. Hsbc Holdings PLC Has $63.47 Million Holdings in Kenvue Inc. $KVUE**
- Source: MarketBeat | 20251201T102616 | Neutral | Relevance: 100%
- Hsbc Holdings PLC reduced its stake in Kenvue Inc. by 6.4% in Q2, with its total holdings valued at $63.47 million. Several other institutional investors also adjusted their positions in Kenvue. The article details Kenvue's stock performance, recent earnings, dividend announcement, and various analyst ratings and price targets.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-10 | Barclays | $18 | $17 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-10 | Barclays | main | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (+0.0%)
- Blackrock Inc.: 7.6% (-1.9%)
- Price (T.Rowe) Assoc: 6.0% (-31.5%)
- State Street Corpora: 6.0% (-0.2%)
- FMR, LLC: 4.7% (-9.3%)

### Key Risks

1. Long-term trend broken: trading 17.5% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.88 indicates undervaluation relative to growth. Forward P/E 15.3x stretched relative to 7% growth. Analyst sentiment positive (1 raises, avg +6%). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.9B |
| Beta | 0.56 |
| 52W Range | $14.02 - $25.17 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.88 |
| Forward P/E | 15.3 |
| Current P/E | 16.4 |
| YoY Growth | 7.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 5.4% to 0.1% (-5.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.9pp (needs >4.0% for momentum thesis). MRS_5 (-1.4%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.82x), long-term trend not supportive. RSI neutral at 57. OFD pattern: +DLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.06% (CS: 53) | Neutral |
| RSI_14 | 56.7 | Neutral |
| MACD Histogram | 0.06 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.057x | Above |
| vs SMA200 | 0.825x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $16.97
- **Stop Loss:** $15.95 (6.0% risk)
- **Target:** $19.01 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 931
- **Position Value:** $15,799.07
- **Portfolio %:** 15.80%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-05 (Est: $0.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.26 | $0.28 | +5.7% |
| 2025Q2 | $0.28 | $0.29 | +2.2% |
| 2025Q1 | $0.23 | $0.24 | +5.4% |
| 2024Q4 | $0.26 | $0.26 | +1.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*